Supply Issues ICU Medical International Limited Percutaneous Sets (ICN 2796)
Important Customer Notice Status Update Type Supply Disruption
Ref: 2025/2796
ICN Number: 2796
- The supply issue with Percutaneous Sets from ICU Medical International Limited is continuing.
- Two products which were subject to intermittent supply are now suspended and unavailable to order:
- FDF10189 and FDF10191.
- Five products remain suspended and unavailable to order:
- FDF10185, FDF10186, FDF1087, FDF10188 and FDF10190.
- Seven product codes remain affected in total.
- See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives and to view the supplier letter.
- The continuing supply issue is being monitored in conjunction with the supplier and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
- The supply Issue is now anticipated to be resolved by 29 August 2025.
- The supplier ICU Medical has informed us that the supply issue with its Percutaneous Sets is ongoing.
- FDF10185, FDF10186, FDF1087, FDF10188, FDF10190 are suspended and unavailable to order.
- FDF10189 and FDF10191 are subject to intermittent supply.
- Seven product codes remain affected in total.
- See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives.
- The supply issue is being monitored and we will continue to review stock to minimise further disruption and update this ICN with the latest information as it becomes available.
- The supply issue is now anticipated to be resolved by 1 July 2025.
- The supply issue with Percutaneous Set products from ICU Medical International Limited is continuing.
- The product listing has been updated with additional alternatives, our online catalogue is in the process of being updated to reflect this.
- We have included a Contents Comparison Matrix to the product listing, detailing contents of alternatives to help customers determine their suitability.
- Four product codes remain suspended and unavailable to order:
- FDF10186, FDF10188, FDF10187 and FDF10190.
- Three product codes remain available to order on an intermittent supply basis:
- FDF10185, FDF10189 and FDF10191.
- Seven product codes remain affected in total.
- See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives.
- The supply issue is still anticipated to be resolved by 31 March 2025.
Change:
- The supplier ICU Medical International Limited has informed us of a supply issue with its Percutaneous Set products.
- Seven product codes are affected in total.
- The supply issue is due to a component shortage.
Impact:
- Four product codes are currently suspended and unavailable to order:
- FDF10185, FDF10186, FDF10188 and FDF10190.
- Three product codes are still available to order on an intermittent supply basis:
- FDF10187, FDF10189 and FDF10191.
- Potential indirect alternative products are available to order through our online catalogue.
- However, some of these products may also be subject to intermittent supply.
- See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives.
- The supply issue is anticipated to be resolved by 31 March 2025.
Next Steps:
- Customers are advised to log into our website to view the potential indirect alternative products.
- All potential alternatives would need to be reviewed by the clinical team within the trust.
- The continuing supply issue is being monitored in conjunction with the supplier and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
- If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.
Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.